Proteotype Diagnostics: Funding, Investors & Team (Oct 2026)
We profile the fundamental building blocks of life, providing cross-sectional snapshots, like a CT scan for your blood. We want to impact both primary and secondary care pathways. Our mission is to light the way in which cancer is diagnosed, treated and monitored. We aspire to deploy at population-level within the UK and globally.
Proteotype Diagnostics has raised $2.0M across 1 funding round on record, the most recent an undisclosed round of $2.0M announced in Oct 2024.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Proteotype Diagnostics Company Profile and Key Stats
Latest funding round on record: Oct 2024.
Proteotype Diagnostics Funding Rounds
Proteotype Diagnostics Founders and Leadership Team
No contact details are on record for this team yet.
Proteotype Diagnostics Funding Compared to Other Biotechnology Startups
Proteotype Diagnostics' latest round of $2.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Proteotype Diagnostics in Biotechnology and Cambridge
Companies Similar to Proteotype Diagnostics
Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify…
OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop…
HydRegen, based in Oxford, UK, is a biotech firm that offers eco-friendly alternatives for the production of…
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
Proteotype Diagnostics Funding FAQs
What does Proteotype Diagnostics do?
We profile the fundamental building blocks of life, providing cross-sectional snapshots, like a CT scan for your blood. We want to impact both primary and secondary care pathways. Our mission is to light the way in which cancer is diagnosed, treated and monitored. We aspire to deploy at population-level within the UK and globally.
How much funding has Proteotype Diagnostics raised?
Proteotype Diagnostics has raised $2.0M across 1 round on record. The most recent is an undisclosed round of $2.0M announced in Oct 2024.
When did Proteotype Diagnostics last raise funding?
Proteotype Diagnostics' most recent funding round on record is an undisclosed round of $2.0M, announced in Oct 2024.
Who founded Proteotype Diagnostics?
FundedIQ lists Emma Yates (Founder) at Proteotype Diagnostics.
Where is Proteotype Diagnostics headquartered?
Proteotype Diagnostics is based in Cambridge, Cambridgeshire, United Kingdom.
How many employees does Proteotype Diagnostics have?
Proteotype Diagnostics is in the 1-10 employee band.
How does Proteotype Diagnostics' funding compare to other Biotechnology startups?
Proteotype Diagnostics' latest round of $2.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Proteotype Diagnostics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Proteotype Diagnostics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.